The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
We expect the global rhinoplasty market to exhibit a CAGR of 6.37% during 2022-2027.
The increasing demand for rhinoplasty procedure to aid in repairing deformities from an injury and improving breathing difficulties caused by birth or structural defect in the nose, is primarily driving the global rhinoplasty market.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective rhinoplasty or nose job procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals or medical equipment.
Based on the treatment type, the global rhinoplasty market has been segmented into augmentation, reduction, post-traumatic, reconstructive, revision, and others. Among these, augmentation treatment currently holds the majority of the total market share.
Based on the technique, the global rhinoplasty market can be divided into open rhinoplasty and closed rhinoplasty. Currently, open rhinoplasty exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global rhinoplasty market include COMEG, GROVER AESTHETICS, Implantech, KLS Martin Group, New York Center for Plastic Surgery, Stryker Corporation, Sunset Cosmetic Surgery, and Surgiform Technologies LLC.
Home Healthcare Market by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at